New York, NY, January 16, 2019 – Churchill Asset Management LLC (“Churchill”) today announced that it served as Sole Lead Arranger for a unitranche financing facility to support Leeds Equity Partners’ investment in LRN Corporation (“LRN”).
LRN is a leading provider of ethics and compliance education, learning technology, data analytics and expert advice that helps companies meet industry regulatory requirement and translate corporate values and operating principles into behavior that drives operational performance, reduces risks and creates sustainable competitive advantages.
About Churchill Asset Management
Based in New York, Churchill Asset Management LLC is a leading provider of senior and unitranche debt financing for middle market companies, particularly those backed by top-tier private equity sponsors. Churchill has $6 billion of committed capital under management and has broad experience in all aspects of the middle market financing business, including structuring, credit analysis, syndication, and deal monitoring and oversight. More information can be found at www.churchillam.com.
# # #
This material is not intended to be a recommendation or investment advice, does not constitute a solicitation to buy or sell securities, and is not provided in a fiduciary capacity. The information provided does not take into account the specific objectives or circumstances of any particular investor, or suggest any specific course of action. Financial professionals should independently evaluate the risks associated with products or services and exercise independent judgment with respect to their clients.
Churchill Asset Management is a registered investment advisor and majority-owned, indirect subsidiary of Teachers Insurance and Annuity Association of America.
Investments in middle market loans are subject to certain risks. Please consider all risks carefully prior to investing in any particular strategy. These investments are subject to credit risk and potentially limited liquidity, as well as interest rate risk, currency risk, prepayment and extension risk, and inflation risk.
709587-INV/MED-O-0120